Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Presentation at Singapore Conference

20 Sep 2012 07:00

RNS Number : 6887M
ViaLogy PLC
20 September 2012
 



VIALOGY PLC ("VIALOGY")

VIALOGY PRESENTS NEW CAPABILITY FOR INCREASING PRIMARY RECOVERY

IN TIGHT CARBONATES AT AAPG SINGAPORE CONFERENCE

 

Pasadena, CA, September 20, 2012. ViaLogy PLC (LSE/AIM: VIY).At a major international energy industry conference today, ViaLogy presented results of work performed for Chevron showing how QuantumRD, its proprietary seismic analysis technology, could significantly increase primary recovery of oil over currently achieved yields in tight carbonate formations. The Chevron-approved presentation to the American Association of Petroleum Geologists (AAPG) in Singapore also provided more details about ViaLogy's current analysis work for the energy supermajor.

In an extensive test analysis, completed earlier this year, ViaLogy's QuantumRD technology was applied to a Chevron 3D seismic dataset to delineate porosity trends in the tight dolomite formations of the lower Permian Basin. The ability to predict effective carbonate porosity in such formations is central to positioning wells and geosteering for horizontal wells. In the blinded test, QuantumRD located the porosity trend that corresponded to the highest producing wells in the formation, something not previously achieved by using best-of-breed conventional analysis or geostatistical software. ViaLogy actually predicted porosity 2 to 3 miles away from known wells, using information that was below the resolution of the seismic data, and that was verified by comparison with the ground truth derived from over 300 wells in the project area.

Other conclusions from the study presented in Singapore were porosity prediction at 20 feet vertical resolution representing a twofold increase in resolution over conventional inversion and geostatistical techniques applied to similar formations.

Utilizing the QuantumRD method could result in a significant reduction of the number of infill wells drilled using standard gridding techniques while increasing recovery from optimally placed wells, thus saving considerable capital expenditure costs. In fact, the study concluded that 40% of poorly performing wells or dry holes drilled using grid-based placement could have been avoided.

ViaLogy CEO Dr. Robert Dean commented, "We regard the results of our work for Chevron as a very important step in establishing QuantumRD as a technology that will be of great value to the upstream Exploration and Production sector. We believe it to be a key improvement over available techniques, and that its widespread use could achieve major savings in the development and production cycle. The dollar value of QuantumRD is to improve primary yields from production areas such as the Permian Basin that are comprised of multiple tight zones. Also importantly, QuantumRD processing could infuse new life into older, expensively acquired seismic surveys that are known to hold promise for large reserves. ViaLogy is dedicated to realizing this potential. Our current work for Chevron and other companies should provide more examples of operating efficiencies in the coming months."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy/Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner, Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMLVLZGZZM
Date   Source Headline
14th Dec 20217:00 amRNSHalf-year Report
6th Dec 20217:00 amRNSNotice of Half-year results
18th Nov 20217:00 amRNSDPYD screening recommended in Spain
28th Oct 20217:00 amRNSRanger® Technology to be presented at Labroots
26th Oct 20217:00 amRNSHalf-year Trading update
29th Sep 20217:00 amRNSResult of AGM
28th Sep 20213:00 pmRNSAGM update
28th Sep 20217:00 amRNSAGM Statement
15th Sep 20217:00 amRNSShare option awards
1st Sep 20217:00 amRNSISO 15189:2012 accreditation received
1st Sep 20217:00 amRNSNotice of AGM and Annual Report 2021
19th Aug 202112:04 pmRNSCOVID-19 Surge testing contract
11th Aug 20217:01 amRNSEarn-out Milestone, Issue of Equity & TVR
11th Aug 20217:00 amRNSAudited Final results&unaudited Q1 business update
6th Aug 20217:00 amRNSConfirmation of Results Date
23rd Jul 20217:00 amRNSNotice of Results
1st Jul 202111:09 amRNSHolding(s) in Company
21st Jun 20217:00 amRNSSecond Strategic Partner for Coastal Genomics
18th Jun 20217:00 amRNSContract Award: DPYD testing kits for NHS Wales
17th Jun 20214:32 pmRNSExercise of Options
9th Jun 20217:00 amRNSMulti-year licence and supply agreement
21st May 20214:30 pmRNSDirector/PDMR Shareholding
19th May 20217:00 amRNSDistribution Partnership
18th May 20217:00 amRNSLaunch of IONA Care NIPT service offering
17th May 20217:00 amRNSFurther testing service agreement for MHC
29th Apr 20217:00 amRNSFull year Trading update
26th Apr 20217:00 amRNSFurther National Microbiology Framework awards
19th Apr 20211:21 pmRNSFurther National Microbiology Framework contract
19th Apr 20217:00 amRNSNational Framework contract award
12th Apr 20217:00 amRNSEarn-out Milestone, Issue of Equity & TVR
6th Apr 20212:43 pmRNSTesting service agreement with MyHealthCheckedplc
6th Apr 20211:54 pmRNSAgreement with Boots for COVID-19 sample kits
29th Mar 20214:00 pmRNSCOVID-19 update
23rd Mar 20217:00 amRNSShare option exercises and awards
19th Mar 20217:00 amRNSTwin Pregnancy study published using IONA® Test
17th Mar 20217:00 amRNSAppointment of VP of Sales North America
11th Mar 20217:00 amRNSYourgene Genomic Services portfolio expansion
1st Mar 20217:00 amRNSFirst US Supply Agreement
22nd Feb 20217:00 amRNSPartnership with NPH
10th Feb 202110:51 amRNSCorrection: Director / PDMR Shareholding
10th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20217:00 amRNSTrading update
13th Jan 20217:00 amRNSDPYD screening recommended in Belgium
11th Jan 20217:00 amRNSClarigene® SARS-CoV-2 Product Update
8th Jan 20217:00 amRNSIssue of Share Options
24th Dec 20207:00 amRNSCOVID-19 update
17th Dec 20207:00 amRNSHalf-year Report
15th Dec 20207:00 amRNSNotice of Half-year Results
2nd Dec 20207:00 amRNSDPYD kits recommended by NHS England
2nd Dec 20207:00 amRNSGenomic testing service launch and Change of name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.